Cite
HARVARD Citation
Li, Z. et al. (n.d.). Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis. Clinical and experimental immunology. pp. 295-314. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, Z. et al. (n.d.). Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis. Clinical and experimental immunology. pp. 295-314. [Online].